257 related articles for article (PubMed ID: 22083261)
1. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.
Kalveram B; Lihoradova O; Indran SV; Ikegami T
J Vis Exp; 2011 Nov; (57):e3400. PubMed ID: 22083261
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
Lihoradova OA; Indran SV; Kalveram B; Lokugamage N; Head JA; Gong B; Tigabu B; Juelich TL; Freiberg AN; Ikegami T
PLoS Negl Trop Dis; 2013; 7(4):e2181. PubMed ID: 23638202
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
[TBL] [Abstract][Full Text] [Related]
4. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.
Lihoradova O; Kalveram B; Indran SV; Lokugamage N; Juelich TL; Hill TE; Tseng CT; Gong B; Fukushi S; Morikawa S; Freiberg AN; Ikegami T
J Virol; 2012 Jul; 86(14):7650-61. PubMed ID: 22573861
[TBL] [Abstract][Full Text] [Related]
5. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
6. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
Indran SV; Lihoradova OA; Phoenix I; Lokugamage N; Kalveram B; Head JA; Tigabu B; Smith JK; Zhang L; Juelich TL; Gong B; Freiberg AN; Ikegami T
J Gen Virol; 2013 Jul; 94(Pt 7):1441-1450. PubMed ID: 23515022
[TBL] [Abstract][Full Text] [Related]
7. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.
Terasaki K; Ramirez SI; Makino S
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005047. PubMed ID: 27711108
[TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.
Ikegami T; Narayanan K; Won S; Kamitani W; Peters CJ; Makino S
PLoS Pathog; 2009 Feb; 5(2):e1000287. PubMed ID: 19197350
[TBL] [Abstract][Full Text] [Related]
10. MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters.
Gowen BB; Westover JB; Sefing EJ; Bailey KW; Nishiyama S; Wandersee L; Scharton D; Jung KH; Ikegami T
Front Microbiol; 2015; 6():651. PubMed ID: 26175722
[TBL] [Abstract][Full Text] [Related]
11. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.
Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T
Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350
[TBL] [Abstract][Full Text] [Related]
12. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
Nishiyama S; Lokugamage N; Ikegami T
J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
[TBL] [Abstract][Full Text] [Related]
13. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
Ikegami T; Won S; Peters CJ; Makino S
J Virol; 2006 Mar; 80(6):2933-40. PubMed ID: 16501102
[TBL] [Abstract][Full Text] [Related]
14. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.
Habjan M; Pichlmair A; Elliott RM; Overby AK; Glatter T; Gstaiger M; Superti-Furga G; Unger H; Weber F
J Virol; 2009 May; 83(9):4365-75. PubMed ID: 19211744
[TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.
Kalveram B; Lihoradova O; Indran SV; Lokugamage N; Head JA; Ikegami T
Virology; 2013 Jan; 435(2):415-24. PubMed ID: 23063407
[TBL] [Abstract][Full Text] [Related]
16. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.
Bouloy M; Janzen C; Vialat P; Khun H; Pavlovic J; Huerre M; Haller O
J Virol; 2001 Feb; 75(3):1371-7. PubMed ID: 11152510
[TBL] [Abstract][Full Text] [Related]
17. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
Kainulainen M; Lau S; Samuel CE; Hornung V; Weber F
J Virol; 2016 Jul; 90(13):6140-7. PubMed ID: 27122577
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of Rift Valley fever virus NSs encoding a partial truncation.
Head JA; Kalveram B; Ikegami T
PLoS One; 2012; 7(9):e45730. PubMed ID: 23029207
[TBL] [Abstract][Full Text] [Related]
19. Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.
Roberts KK; Hill TE; Davis MN; Holbrook MR; Freiberg AN
J Gen Virol; 2015 Jul; 96(Pt 7):1651-1663. PubMed ID: 25759029
[TBL] [Abstract][Full Text] [Related]
20. Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine.
Murakami S; Terasaki K; Makino S
Methods Mol Biol; 2016; 1403():187-206. PubMed ID: 27076131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
